{"id":"placebo-for-topiramate","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL220492","moleculeType":"Small molecule","molecularWeight":"339.37"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological systems and serves as a control in clinical trials for Topiramate.","oneSentence":"Placebo does not have a pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:26.129Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control for Topiramate efficacy in clinical trials"}]},"trialDetails":[{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":"Obesity","enrollment":120},{"nctId":"NCT04050293","phase":"PHASE4","title":"Therapy for Migraine Prevention in Children 6-11 Years of Age","status":"TERMINATED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2020-07-14","conditions":"Migraine Disorders, Headache Disorders","enrollment":26},{"nctId":"NCT05209984","phase":"PHASE3","title":"A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT02273804","phase":"PHASE3","title":"Topiramate and Severe Obesity","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-01","conditions":"Obese Children and Adolescents","enrollment":18},{"nctId":"NCT01182766","phase":"PHASE2, PHASE3","title":"New Treatment for Alcohol and Nicotine Dependence","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2011-11-01","conditions":"Alcohol Dependence, Nicotine Dependence","enrollment":236},{"nctId":"NCT06299891","phase":"PHASE2","title":"Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity","status":"RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2025-03-01","conditions":"Hypothalamic Obesity, Hypothalamic Tumor, Craniopharyngioma","enrollment":24},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT05748483","phase":"PHASE3","title":"Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2023-10-07","conditions":"Migraine","enrollment":545},{"nctId":"NCT04095104","phase":"PHASE2","title":"Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-15","conditions":"Obesity, Morbid, Bariatric Surgery, Adolescent","enrollment":13},{"nctId":"NCT04298203","phase":"PHASE2","title":"Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-04","conditions":"Obesity","enrollment":100},{"nctId":"NCT00394095","phase":"PHASE4","title":"Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-12","conditions":"Bipolar Disorder, Weight Gain","enrollment":31},{"nctId":"NCT03667846","phase":"PHASE2","title":"Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2019-10-10","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":150},{"nctId":"NCT01950520","phase":"PHASE2","title":"Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-02-07","conditions":"Healthy Volunteers","enrollment":47},{"nctId":"NCT05582837","phase":"PHASE4","title":"Treatment of Meniere's Disease With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2022-08-01","conditions":"Ménière","enrollment":100},{"nctId":"NCT01765218","phase":"PHASE1, PHASE2","title":"Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy","status":"TERMINATED","sponsor":"Kristin R Hoffman","startDate":"2013-02","conditions":"Hypoxic Ischemic Encephalopathy","enrollment":34},{"nctId":"NCT00812006","phase":"PHASE3","title":"A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-03-24","conditions":"Migraine","enrollment":108},{"nctId":"NCT05378503","phase":"PHASE4","title":"Phase IV Study of Qsymia in Obese Patients","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2021-09-17","conditions":"Obesity","enrollment":232},{"nctId":"NCT03176953","phase":"PHASE2, PHASE3","title":"Topiramate and Prolonged Exposure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-11-01","conditions":"PTSD and Alcohol Use Disorder","enrollment":100},{"nctId":"NCT02878798","phase":"PHASE2","title":"Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2018-02-12","conditions":"Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome","enrollment":132},{"nctId":"NCT05834062","phase":"PHASE2","title":"Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2023-10-17","conditions":"Obesity, Adolescent","enrollment":""},{"nctId":"NCT04408586","phase":"PHASE4","title":"Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-06-03","conditions":"Obesity","enrollment":80},{"nctId":"NCT04721873","phase":"PHASE2","title":"Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2020-12-18","conditions":"Colitis, Ulcerative, Obesity","enrollment":40},{"nctId":"NCT04404439","phase":"PHASE4","title":"Treatment of Tinnitus With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2019-09-26","conditions":"Tinnitus, Subjective, Tinnitus","enrollment":150},{"nctId":"NCT03922945","phase":"PHASE4","title":"A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2019-05-02","conditions":"Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight","enrollment":223},{"nctId":"NCT01408641","phase":"NA","title":"Topiramate for Alcohol Use in Posttraumatic Stress Disorder","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2012-09","conditions":"Alcohol Dependence, Alcoholism, Alcohol Abuse","enrollment":4},{"nctId":"NCT02371889","phase":"PHASE2","title":"A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-12-18","conditions":"Alcoholism, Alcohol Use Disorder (AUD)","enrollment":320},{"nctId":"NCT01749215","phase":"PHASE4","title":"A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2013-02","conditions":"Alcohol Dependence, Posttraumatic Stress Disorder (PTSD)","enrollment":151},{"nctId":"NCT00571246","phase":"PHASE3","title":"The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2012-06","conditions":"Alcohol Dependence, Post Traumatic Stress Disorder","enrollment":""},{"nctId":"NCT03120468","phase":"EARLY_PHASE1","title":"Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder","status":"UNKNOWN","sponsor":"Nassima Ait-Daoud Tiouririne","startDate":"2017-05-01","conditions":"Alcoholism","enrollment":16},{"nctId":"NCT01700387","phase":"PHASE4","title":"A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency","status":"COMPLETED","sponsor":"Cady, Roger, M.D.","startDate":"2012-10","conditions":"Chronic Migraine","enrollment":20},{"nctId":"NCT00167245","phase":"PHASE2","title":"Topiramate for Alcohol and Cocaine Dependence","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2004-09","conditions":"Alcoholism, Cocaine Dependence","enrollment":170},{"nctId":"NCT02239913","phase":"PHASE1","title":"Topiramate-Phentermine Combinations for Cocaine Dependence","status":"COMPLETED","sponsor":"University of Kentucky","startDate":"2014-09","conditions":"Cocaine Use Disorder","enrollment":38},{"nctId":"NCT01811940","phase":"PHASE2, PHASE3","title":"Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2013-07","conditions":"Cocaine Dependence","enrollment":169},{"nctId":"NCT00421603","phase":"PHASE2","title":"A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-02","conditions":"Cocaine Dependence","enrollment":81},{"nctId":"NCT01789047","phase":"PHASE2","title":"Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2013-03","conditions":"Idiopathic Parkinson's Disease, Drug Induced Dyskinesia","enrollment":42},{"nctId":"NCT01713946","phase":"PHASE3","title":"A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-04-29","conditions":"Tuberous Sclerosis Complex-associated Refractory Seizures","enrollment":366},{"nctId":"NCT02553824","phase":"PHASE1","title":"FDA Approved Medication to Reduce Binge Eating and/or Purging","status":"COMPLETED","sponsor":"Stanford University","startDate":"2015-10-30","conditions":"Binge Eating Disorder, Bulimia Nervosa","enrollment":22},{"nctId":"NCT02810483","phase":"PHASE3","title":"Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-12","conditions":"Prader-Willi Syndrome","enrollment":69},{"nctId":"NCT00626925","phase":"PHASE4","title":"Topiramate Treatment of Problem Drinkers","status":"COMPLETED","sponsor":"UConn Health","startDate":"2008-02","conditions":"Alcohol Drinking","enrollment":200},{"nctId":"NCT00393978","phase":"PHASE4","title":"Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-11","conditions":"Bipolar Disorder, Cannabis-Related Disorder","enrollment":75},{"nctId":"NCT00755716","phase":"PHASE3","title":"Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study","status":"COMPLETED","sponsor":"UConn Health","startDate":"2006-04","conditions":"Tobacco Dependence","enrollment":57},{"nctId":"NCT00685178","phase":"PHASE2","title":"Clinical Trial of Topiramate for Cocaine Addiction","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2007-02","conditions":"Cocaine Dependence","enrollment":250},{"nctId":"NCT01859013","phase":"PHASE2","title":"Topiramate in Adolescents With Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2013-06","conditions":"Obesity, Morbid, Obesity, Weight Loss","enrollment":34},{"nctId":"NCT00550394","phase":"PHASE4","title":"Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2008-04","conditions":"Bipolar Disorder, Alcohol Abuse","enrollment":56},{"nctId":"NCT02138058","phase":"PHASE2","title":"Topiramate Trial for Compulsive Buying","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2015-01","conditions":"Compulsive Shopping","enrollment":42},{"nctId":"NCT00345371","phase":"PHASE2","title":"Topiramate for the Treatment of Methamphetamine Dependence - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2006-04","conditions":"Methamphetamine","enrollment":140},{"nctId":"NCT00802412","phase":"PHASE2","title":"Topiramate to Aid Smoking Cessation in Alcohol Dependent Men","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2009-01","conditions":"Nicotine Dependence, Alcohol Dependence","enrollment":132},{"nctId":"NCT00572117","phase":"PHASE4","title":"Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-08","conditions":"Bipolar Disorder, Alcoholism, Alcohol Dependence","enrollment":12},{"nctId":"NCT01764685","phase":"PHASE2","title":"Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"Heavy Drinking, HIV, Alcohol Dependence","enrollment":4},{"nctId":"NCT00862563","phase":"PHASE2","title":"Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2009-05","conditions":"Alcoholism, Alcohol Dependence, Alcohol Abuse","enrollment":85},{"nctId":"NCT00563368","phase":"PHASE3","title":"A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2007-12","conditions":"Obesity","enrollment":756},{"nctId":"NCT00732108","phase":"NA","title":"Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2008-11","conditions":"Migraine, Headache, Dizziness","enrollment":""},{"nctId":"NCT01834404","phase":"PHASE4","title":"Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-04","conditions":"Obesity","enrollment":24},{"nctId":"NCT00725920","phase":"PHASE4","title":"Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2007-01","conditions":"Posttraumatic Stress Disorder","enrollment":35},{"nctId":"NCT00216619","phase":"PHASE3","title":"The Prolonged Use of Topiramate for Preventing Migraine Headaches","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2003-11","conditions":"Migraine","enrollment":834},{"nctId":"NCT01087736","phase":"PHASE4","title":"Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-04","conditions":"PTSD, Alcohol Abuse, Alcoholism","enrollment":30},{"nctId":"NCT00113815","phase":"PHASE3","title":"Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-05","conditions":"Partial Seizure Disorder, Epilepsy, Seizures","enrollment":118},{"nctId":"NCT00806260","phase":"PHASE2","title":"A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2008-12","conditions":"Overweight, Obesity","enrollment":80},{"nctId":"NCT01081795","phase":"PHASE2","title":"A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2007-04","conditions":"Migraine","enrollment":387},{"nctId":"NCT01843699","phase":"PHASE2","title":"Topiramate Trial for Pathological Gamblers","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2009-06","conditions":"Pathological Gambling","enrollment":38},{"nctId":"NCT00862095","phase":"PHASE4","title":"Medical Therapies for Chronic Post-Traumatic Headaches","status":"TERMINATED","sponsor":"Madigan Army Medical Center","startDate":"2008-06","conditions":"Headache","enrollment":64},{"nctId":"NCT00448825","phase":"PHASE3","title":"Novel Pharmacotherapy for Dual Dependence","status":"UNKNOWN","sponsor":"Bankole Johnson","startDate":"2007-03","conditions":"Alcohol Dependence, Cocaine Dependence","enrollment":180},{"nctId":"NCT00006205","phase":"PHASE2","title":"Alcohol Dependency Study: Combining Medication Treatment for Alcoholism","status":"UNKNOWN","sponsor":"Bankole Johnson","startDate":"2005-03","conditions":"Alcoholism","enrollment":320},{"nctId":"NCT00745251","phase":"PHASE1, PHASE2","title":"A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2008-08","conditions":"Sleep Apnea","enrollment":45},{"nctId":"NCT00796367","phase":"PHASE3","title":"A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2008-12","conditions":"Obesity","enrollment":676},{"nctId":"NCT00223626","phase":"PHASE2","title":"Topiramate to Reduce Cocaine Dependence","status":"COMPLETED","sponsor":"Bankole Johnson","startDate":"2007-01","conditions":"Cocaine-Related Disorders","enrollment":25},{"nctId":"NCT00249691","phase":"PHASE3","title":"Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1","status":"UNKNOWN","sponsor":"Bankole Johnson","startDate":"2005-10","conditions":"Cocaine-Related Disorders","enrollment":180},{"nctId":"NCT00769158","phase":"PHASE1","title":"Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study","status":"COMPLETED","sponsor":"Bankole Johnson","startDate":"2008-10","conditions":"Alcoholism","enrollment":4},{"nctId":"NCT00463775","phase":"PHASE3","title":"Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence","status":"WITHDRAWN","sponsor":"Elizabeth Ralevski","startDate":"2007-03","conditions":"Alcohol Dependence, Borderline Personality Disorder","enrollment":""},{"nctId":"NCT00772031","phase":"PHASE3","title":"NINDS CRC Chronic Migraine Treatment Trial","status":"COMPLETED","sponsor":"Anne Lindblad","startDate":"2008-10","conditions":"Chronic Migraine","enrollment":191},{"nctId":"NCT00035802","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2002-01","conditions":"Bipolar Disorder, Affective Disorders, Psychotic, Mood Disorders","enrollment":13},{"nctId":"NCT01145677","phase":"PHASE2, PHASE3","title":"Efficacy of Topiramate for Hospitalized Patients With Alcoholism","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2010-06","conditions":"Alcohol Dependence","enrollment":90},{"nctId":"NCT00210912","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2003-09","conditions":"Migraine","enrollment":328},{"nctId":"NCT00210535","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-06","conditions":"Migraine, Vascular Headaches","enrollment":110},{"nctId":"NCT00240721","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2000-10","conditions":"Bipolar Disorders, Mood Disorders, Affective Disorders, Psychotic","enrollment":363},{"nctId":"NCT00231673","phase":"PHASE2","title":"A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2001-07","conditions":"Diabetic Neuropathies, Diabetes Mellitus, Type 2, Polyneuropathies","enrollment":72},{"nctId":"NCT00237302","phase":"PHASE3","title":"A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children","status":"COMPLETED","sponsor":"Ortho-McNeil Neurologics, Inc.","startDate":"2001-07","conditions":"Migraine","enrollment":162},{"nctId":"NCT00037674","phase":"PHASE3","title":"A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2001-01","conditions":"Bipolar Disorder","enrollment":434},{"nctId":"NCT00307619","phase":"PHASE3","title":"An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.","status":"COMPLETED","sponsor":"Janssen-Cilag Farmaceutica Ltda.","startDate":"2003-11","conditions":"Binge Eating","enrollment":73},{"nctId":"NCT00253175","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2000-10","conditions":"Vascular Headaches, Migraine","enrollment":211},{"nctId":"NCT00243984","phase":"PHASE3","title":"Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome","status":"SUSPENDED","sponsor":"Northeastern Ohio Universities College of Medicine","startDate":"2005-03","conditions":"Metabolic Syndrome X, Diabetes Mellitus, Type 2","enrollment":90},{"nctId":"NCT00296959","phase":"PHASE2","title":"Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease","status":"TERMINATED","sponsor":"University Health Network, Toronto","startDate":"2004-09","conditions":"Parkinson's Disease","enrollment":20},{"nctId":"NCT00004776","phase":"PHASE3","title":"Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"1993-11","conditions":"Lennox-Gastaut Syndrome","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":789,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for Topiramate","genericName":"Placebo for Topiramate","companyName":"AbbVie","companyId":"abbvie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo does not have a pharmacological effect. Used for Control for Topiramate efficacy in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}